Ningbo Menovo Pharmaceutic (603538.SS) traded flat 0 % during a 24 hours period ending at 04:33 PM Central Europe on Tuesday 27th. One Ningbo Menovo Pharmaceutic stock can currently be bought for about CNY 20.33 on popular exchanges. Current supply of Ningbo Menovo Pharmaceutic stocks is 339.9 mn. Ningbo Menovo Pharmaceutic has a current market capitalization of CNY 7.1 bn and approximately CNY 352.2 mn worth of Ningbo Menovo Pharmaceutic was traded on exchanges in the last 24 hours. Since last month end, Ningbo Menovo Pharmaceutic has traded -19.14 % down. Simple moving average of last 200 days is at CNY 27.68. The highest price of past 52 weeks was recorded at CNY 50.28 on 05/07/2026. 52 weeks low was at CNY 13.55 on 12/17/2025.

Summary of the latest news for Ningbo Menovo Pharmaceutic

Ningbo Menovo Pharmaceutical has announced that it has obtained a European CEP certificate from the European Directorate for the Quality of Medicines. The certificate, issued by the European Directorate for Quality of Medicines, confirms the compliance of the company’s pregabalin API with European Pharmacopeia standards. Menovo submitted its application in early May and received the certificate in late October. The approval enables the company to produce pregabalin preparations, which are used for neuropathic pain, adjunctive treatment of seizures, and generalized anxiety disorder. Menovo is one of five domestic companies holding CEP certificates, and the pregabalin API has been a significant contributor to global sales in recent years.

Here is how related stocks have performed in the past 24 hours:

  • Kidswant Digital Technolog (301078.SZ) traded flat 0 % and now trades at CNY 6.6. Kidswant Digital Technolog has a market capitalisation of CNY 8.5 bn. Kidswant Digital Technolog has a current price to earnings ratio of 27.04.

  • Jiangxi Ganneng (000899.SZ) traded flat 0 % and now trades at CNY 8.53. Current market capitalisation for Jiangxi Ganneng is CNY 8.5 bn. Jiangxi Ganneng has a current price to earnings ratio of 15.47.

  • Ruifeng Power (2025.HK) traded up 2.05 % and now trades at HKD 12.25. Ruifeng Power has a market capitalisation of HKD 10 bn. Current price/earnings ratio for Ruifeng Power is 392.

  • China National Electric Ap (688128.SS) traded flat 0 % and now trades at CNY 20.66. Current market capitalisation for China National Electric Ap is CNY 8.5 bn. Current price/earnings ratio for China National Electric Ap is 16.4.

  • Shanghai Fengyuzhu Culture (603466.SS) traded flat 0 % and now trades at CNY 13.87. Shanghai Fengyuzhu Culture has a market capitalisation of CNY 8.5 bn. On October 26, the physical‑AI sector continued its momentum from the previous week, with several technology stocks posting gains. Among the most notable moves were Shenzhen’s Shuanglong Digital and Tianyu Science and Technology, both extending their upward trajectory. Other firms in the space, such as FanTu Data, Enke Technology, Zhongcheng Technology, Fengyu Zhuzhi, and Zhongwang Software, also saw their shares rise. Market commentary highlighted a shift in expectations, with JPMorgan upgrading the rating of Yushuzhike-W, while analysts from Nomura reported a dramatic reduction in computational demands for motion‑control training, lowering entry barriers for participants. Additionally, a new dataset, AGIBOT WORLD 2026 Phase 4 on embodied reasoning, was released, marking a milestone for real‑world physical agent data.

About Ningbo Menovo Pharmaceutic

Ningbo Menovo Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical sector. The company, located in Ningbo, China, specializes in manufacturing pharmaceutical products. It produces and sells both pharmaceutical intermediates and active pharmaceutical ingredients. The main market for its products is China. You can find more information about the company and its offerings on its website at www.menovopharm.com . The company’s stock is traded on the Shanghai Stock Exchange.